Platelet Indices in Inflammatory Bowel Diseases
Observational · No treatment assigned · Sites not listed yet · Assiut University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Diseases. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 and older
- Any sex
- Healthy volunteers accepted
Some of the main requirements, copied from the record:
- a. Inclusion criteria:
- Adult patients (age >18) with confirmed diagnosis of UC , Crohn's b. Exclusion criteria:
- Hematologic malignancies or disorders.
Plus 2 more requirement(s). Only the trial team can confirm whether you qualify.
What's involved
- About 84 participants are expected to take part.
- Start date: 2025-12-30 (planned).
- Main results expected around 2030-05-01 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- This study aims to evaluate the correlation between platelet indices and disease activity in IBD (From study enrollment up to 5 years.)
In the researchers’ words
Inflammatory bowel disease (IBD) is a chronic, immune-mediated condition characterized by relapsing inflammation of the gastrointestinal tract. It primarily includes two subtypes: ulcerative colitis (UC) and Crohn's disease (CD), both of which have shown a rising incidence globally over recent decades .The pathogenesis of IBD is complex and multifactorial, involving a dynamic interplay of genetic susceptibility,…
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Diseases |
| Lead sponsor | Assiut University |
| Enrollment | 84 (estimated) |
| Start date | 2025-12-30 |
| Primary completion (est.) | 2030-05-01 |
| First posted | 2026-01-06 |
| Last updated | 2026-01-06 |
| Official title | Platelet Indices in Inflammatory Bowel Diseases |
| ClinicalTrials.gov ID | NCT07320443 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * a. Inclusion criteria: * Adult patients (age >18) with confirmed diagnosis of UC , Crohn's b. Exclusion criteria: * Hematologic malignancies or disorders. * Pregnancy * Use of antiplatelet or anticoagulant drugs
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.